Skip to main content
. 2020 Apr 21;9(3):LMT32. doi: 10.2217/lmt-2020-0004

Figure 2. . Propensity matched Kaplan–Meier curve showing benefit to stereotactic ablative body radiotherapy with a median overall survival 34.7 versus 23.7 months; p = 0.02.

Figure 2. 

CFRT: Conventionally fractionated radiation therapy; SABR: Stereotactic ablative body radiotherapy.